Starsource Multitrade Ltd (CHEMOPH) — shareholding pattern, promoter holding, financials and share price
About Starsource Multitrade Ltd (CHEMOPH)
Starsource Multitrade Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as CHEMOPH and on the BSE under scrip code 506365. Its ISIN is INE320M01019.
The Chemo Pharma Laboratories Limited was established in 1942 and was making Pharmaceuticals and bulk drugs. However due to increased competition, Company disposed the business. Company is in advanced stage of negotiation to diversify and take over a sick company [1]
Chemo Pharma Laboratories Ltd., established in 1942, originally operated in pharmaceuticals, producing bulk drugs.
Due to heightened competition, Chemo Pharma exited its pharmaceutical business, paying down liabilities completely.
Listed peers in Pharmaceuticals: Zenith Health Care Ltd, Dipna Pharmachem Ltd, Ortin Global Ltd, Saroja Pharma Industries India Ltd, Beryl Drugs Ltd, Unjha Formulations Ltd.
Valuation & Returns
10 Jul 2026At ₹97 a share on 10 Jul 2026, Starsource Multitrade Ltd (CHEMOPH) was valued at a price-to-earnings ratio of -1.23x against an industry P/E of 36.41x and a price-to-book of 1.11x on a book value of ₹87.63 per share as of Mar 2025. Solomo computes return on equity of -90.3% and return on capital employed of -90.3% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -1.23x
- Industry P/E
- 36.41x
- P/B
- 1.11x
- EPS (TTM)
- ₹-79.13
- Book value / share
- ₹87.63
- ROE
- -90.3%
- ROCE
- -90.3%
- ROA
- -88.91%
- Debt / equity
- 0x
- Dividend yield
- 0%
- 52-week range
- ₹75 – ₹152.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2016In the year ended Mar 2016, Starsource Multitrade Ltd (CHEMOPH) reported net profit of ₹-1.45 crore and earnings per share of ₹-9.67. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, net profit ₹-0.07 crore (standalone).
| Metric | Mar 2016 |
|---|---|
| Revenue (₹ cr) | 0 |
| Net profit (₹ cr) | -1.45 |
| EPS (₹) | -9.67 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Profit growth | 5.20% | -3.79% | -15.14% | -71.67% |
| Stock price CAGR | 14% | 25% | 33% | -35% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 27.89% of Starsource Multitrade Ltd (CHEMOPH) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.37%. Market capitalisation was ₹15 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: KSHEMTECH MEDIA PRIVATE LIMITED 3.64%, RAVINDRA SOMANI 3.16%, SUDHIR HARILAL KALE 2.33%, SUDHANSHU KANDA 1.81%, HUF 1.08%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 27.89% | - | - | 0.37% | 72.11% |
| Mar 2026 | 27.89% | - | - | 0.37% | 72.11% |
| Dec 2025 | 27.89% | - | - | 0.37% | 72.11% |
| Sep 2025 | 27.89% | - | - | 0.37% | 72.11% |
| Jun 2025 | 27.89% | - | - | 0.37% | 72.11% |
| Mar 2025 | 27.89% | - | - | 0.37% | 72.11% |
| Dec 2024 | 27.89% | - | - | 0.37% | 72.11% |
| Sep 2024 | 27.89% | - | - | 0.37% | 72.11% |